%A Kang Xiaoyan， Qu Liyan, Song Xia %T BRAF and targeted treatment for non-small cell lung cancer %0 Journal Article %D 2016 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2016.08.016 %P 625-627 %V 43 %N 8 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_10029.shtml} %8 2016-08-08 %X B-Raf kinase (BRAF) gene is a driver mutation, and is an effective target in the treatment of nonsmall cell lung cancer （NSCLC）. Studies have shown that BRAF inhibitors are effective for treatment of NSCLC with BRAF mutant. It is important to understand the clinicopathologic features and the research progress of BRAF inhibitors for the individual treatment of NSCLC.